Top US lawyers to fight clinical labs case against FDA LDT guidance
This article was originally published in SRA
Executive Summary
The American Clinical Laboratory Association has hired former US Solicitor General Paul Clement and Harvard Law Professor Laurence Tribe – prominent attorneys with Supreme Court experience – to help it 'persuade' the US Food and Drug Administration to withdraw its proposed laboratory-developed test (LDT) guidance1-3.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.